Results 121 to 130 of about 21,451 (259)

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease, with a rising incidence in the elderly. BP is associated with multiple triggering factors, including drug exposure. However, evidence in this respect is limited, and the underlying immune mechanisms remain unknown.
Belen de Nicolas‐Ruanes   +17 more
wiley   +1 more source

Plastics in dermatology: A review and solutions

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This review explores the environmental and health impacts of plastics, particularly microplastics in dermatological products. It discusses the plastic life cycle, routes of exposure, health risks and provides science‐based recommendations to reduce plastic use in dermatology.
Eugene Tan, Susanne Saha, Dennis Niebel
wiley   +1 more source

Allergic Contact Dermatitis to 1.6‐Hexanediol Diacrylate in Ski Boots

open access: yes
Contact Dermatitis, EarlyView.
Nadia Raison‐Peyron   +3 more
wiley   +1 more source

Completed suicide in patients with skin disease: A systematic review and meta‐analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Several skin diseases have been associated with suicidality. However, the term ‘suicidality’ encompasses ideation, which weakens the conclusions. In contrast, the much stronger endpoint of completed suicide and skin disease remains ambiguous. This was the focus of this study.
B. Hrvatin Stancic   +5 more
wiley   +1 more source

Lettuce Anaphylaxis in a Florist With Hand Dermatitis and Contact Allergy to the Compositae (Asteraceae) Family of Plants

open access: yes
Contact Dermatitis, EarlyView.
Lara Obermeyer   +5 more
wiley   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A core domain set for hand eczema was developed in an international consensus study with an online Delphi survey and a consensus meeting. Signs and symptoms of hand eczema, related quality of life and control over time should be measured in all future hand eczema therapeutic trials.
Henriette Rönsch   +38 more
wiley   +1 more source

Home - About - Disclaimer - Privacy